These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18186267)

  • 1. [Adjuvant concurrent chemoradiotherapy for resected locally advanced lung cancer outpatients].
    Endo C; Kondo T
    Kyobu Geka; 2008 Jan; 61(1):15-8. PubMed ID: 18186267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safety evaluation of adjuvant chemotherapy by weekly paclitaxel combined with weekly carboplatin in patients with postoperative non-small cell lung cancer].
    Hirose T; Nagao T; Kajikawa A; Sumi T; Sugimoto T; Hirose Y; Yoshida M; Kenzaki K
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1397-400. PubMed ID: 17876136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
    Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer.
    Tell R; Sederholm C; Klintenberg C; Franksson L; Brandén E; Hillerdal G; Lönn U; Lindén CJ; Ewers SB; Lamberg K; Mrazek E; Lödén B; Sjögren A; Linné T; Friesland S; Sirzén F
    Anticancer Res; 2008; 28(5B):2851-7. PubMed ID: 19031924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative safety evaluation of first- and second-line therapy with carboplatin + paclitaxel for advanced non-small cell lung cancer].
    Morihata K; Kimura M; Okada K; Usami E; Nakao T; Yoshimura T; Hayase K; Yasuda T
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):45-50. PubMed ID: 20087031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience.
    Allen AM; Mentzer SJ; Yeap BY; Soto R; Baldini EH; Rabin MS; Sugarbaker DJ; Bueno R
    Cancer; 2008 Mar; 112(5):1106-13. PubMed ID: 18286507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.
    Rodríguez N; Algara M; Foro P; Lacruz M; Reig A; Membrive I; Lozano J; López JL; Quera J; Fernández-Velilla E; Sanz X
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):810-7. PubMed ID: 18755556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.
    Pignata S; Breda E; Scambia G; Pisano C; Zagonel V; Lorusso D; Greggi S; De Vivo R; Ferrandina G; Gallo C; Perrone F
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):229-36. PubMed ID: 18243011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience of postoperative adjuvant chemotherapy of lung cancer at outpatient department].
    Notsuda H; Endo C; Sakurada A; Okada Y; Kondo T
    Kyobu Geka; 2009 Dec; 62(13):1111-5; discussion 1115--7. PubMed ID: 19999085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancer.
    Iranzo V; Bremnes RM; Almendros P; Gavilá J; Blasco A; Sirera R; Camps C
    Lung Cancer; 2009 Jan; 63(1):63-7. PubMed ID: 18550204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer.
    Edelman MJ; Suntharalingam M; Burrows W; Kwong KF; Mitra N; Gamliel Z; Riley M; Cooper LB; Kennedy NL; Buskirk S; Hausner P; Doyle LA; Krasna MJ
    Ann Thorac Surg; 2008 Sep; 86(3):903-10. PubMed ID: 18721580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant carboplatin and vinorelbine followed by chemoradiotherapy in locally advanced head and neck or oesophageal squamous cell carcinoma: a phase II study in elderly patients or patients with poor performance status.
    Koussis H; Scola A; Bergamo F; Tonello S; Basso U; Karahontzitis P; Chiarion-Sileni V; Pasetto L; Ruol A; Loreggian L; Lora O; Bottin R; Marioni G; Donach M; Jirillo A
    Anticancer Res; 2008; 28(2B):1383-8. PubMed ID: 18505084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
    Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advanced lung cancer with mediastinal lymph node metastasis and recurrence of brain metastasis completely responsive to combination chemotherapy and gamma knife radiosurgery--a case report].
    Higaki N; Soma I; Hayashi N; Nakano K; Murakami M; Hayashida H; Kan K; Ichihara T; Aizawa N; Saito N; Niju T; Ikeda T; Sakon M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2111-3. PubMed ID: 20037340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concurrent chemoradiotherapy for advanced cervical cancer--a pilot study].
    Kodama J; Hashimoto I; Seki N; Hongo A; Mizutani Y; Miyagi Y; Yoshinouchi M; Kudo T
    Gan To Kagaku Ryoho; 2001 Mar; 28(3):351-5. PubMed ID: 11265403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: preliminary results.
    Ohguri T; Imada H; Narisada H; Yahara K; Morioka T; Nakano K; Miyaguni Y; Korogi Y
    Int J Hyperthermia; 2009 Mar; 25(2):160-7. PubMed ID: 19337916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
    Belani CP; Ramalingam S; Perry MC; LaRocca RV; Rinaldi D; Gable PS; Tester WJ
    J Clin Oncol; 2008 Jan; 26(3):468-73. PubMed ID: 18202422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant chemotherapy of paclitaxel plus carboplatin in uterine corpus cancer--comparison with cisplatin, adriamycin plus cyclophosphamide].
    Tanase Y; Kawaguchi R; Haruta S; Kanayama S; Yamada Y; Kobayashi H
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):945-50. PubMed ID: 16835485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.